A
Alseres Pharmaceuticals Inc. Stock Analysis ALSE
Alseres Pharmaceuticals, Inc. is a biotechnology company, which engages in the development of diagnostic and therapeutic products for disorders in the central nervous system. The company is headquartered in Auburndale, Massachusetts. The firm is engaged in the development of diagnostic and therapeutic products for disorders in the central nervous system (CNS). The firm's product candidate is Altropane. The firm's Altropane product is a molecular imaging agent used to diagnose Parkinson's disease and dementia. The firm is focused on entering partnerships to ensure development and commercialization of its product.
Read More Alseres Pharmaceuticals Inc (ALSE) Chart
Key Statistics of Alseres Pharmaceuticals Inc (ALSE)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.01Volume
66.00P/E Ratio (TTM)
-52 Week Range
Market Cap
150.00KAvg. Volume
66.00Dividend Yield
-Financial Metrics & Statements of Alseres Pharmaceuticals Inc (ALSE)
FAQ's for Alseres Pharmaceuticals Inc (ALSE)
- According to Musaffa’s Shariah screening methodology, Alseres Pharmaceuticals Inc (ALSE) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.